PMV Pharmaceuticals (PMVP) director gifts 84K stock options to trust
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
PMV Pharmaceuticals director Carol Giltner Gallagher reported option grants and internal transfers involving 42,000-share stock options. She received a stock option for 42,000 shares of common stock at an exercise price of $1.19 per share, expiring on June 4, 2036.
According to a footnote, these options vest on the earlier of June 4, 2027 or the issuer’s next annual meeting of stockholders. The filing also shows bona fide gifts moving options covering a total of 84,000 underlying shares, including a transfer to The Gallagher Revocable Trust dated May 10, 2011, for which she serves as trustee. These are non-market, gift and grant transactions rather than open-market buys or sells.
Positive
- None.
Negative
- None.
Insider Trade Summary
84,000 shares gifted
Mixed
3 txns
Insider
Gallagher Carol Giltner
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 42,000 | $0.00 | -- |
| Gift | Stock Option (right to buy) | 42,000 | $0.00 | -- |
| Gift | Stock Option (right to buy) | 42,000 | $0.00 | -- |
Holdings After Transaction:
Stock Option (right to buy) — 42,000 shares (Direct, null);
Stock Option (right to buy) — 42,000 shares (Indirect, See footnote)
Footnotes (1)
- Shares subject to the option vest on the earlier of (i) June 4, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders. The securities are held of record by The Gallagher Revocable Trust dated May 10, 2011 for which the reporting person serves as a trustee.
Key Figures
Option grant size: 42,000 shares
Gifted option shares: 84,000 shares
Exercise price: $1.19 per share
+4 more
7 metrics
Option grant size
42,000 shares
Stock option covering common stock granted on June 4, 2026
Gifted option shares
84,000 shares
Total underlying shares in bona fide gift transactions
Exercise price
$1.19 per share
Conversion or exercise price of the stock options
Expiration date
June 4, 2036
Option expiration for all reported stock option entries
Vesting trigger date
June 4, 2027
Options vest on this date or on next annual meeting date
Gift transaction count
2 transactions
Number of bona fide gift entries in transaction summary
Net buy/sell direction
neutral
Transaction summary shows no net open-market buying or selling
Key Terms
Stock Option (right to buy), bona fide gift, conversion or exercise price, Revocable Trust, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
bona fide gift financial
"transaction_code_description: Bona fide gift"
A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.
conversion or exercise price financial
"conversion_or_exercise_price: 1.1900"
Revocable Trust financial
"held of record by The Gallagher Revocable Trust dated May 10, 2011"
A revocable trust is a legal arrangement where the person who creates it keeps control and can change or cancel the trust at any time, while naming who will manage and receive the assets later. Think of it like a flexible folder for your investments and property that can be relabeled or reworked as circumstances change; it matters to investors because it determines how ownership is recorded, how easily assets transfer on incapacity or death, and whether holdings bypass public probate proceedings.
vest financial
"Shares subject to the option vest on the earlier of June 4, 2027"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
FAQ
What insider transactions did PMV Pharmaceuticals (PMVP) report for Carol Giltner Gallagher?
The filing shows Carol Giltner Gallagher received a stock option grant for 42,000 PMV Pharmaceuticals shares and reported bona fide gift transfers involving options over 84,000 underlying shares. These are non-market gifts and grants, not open-market purchases or sales.
What are the key terms of Carol Giltner Gallagher’s 42,000 PMVP stock option?
The option covers 42,000 shares of PMV Pharmaceuticals common stock at an exercise price of $1.19 per share and expires June 4, 2036. It vests on June 4, 2027 or on the date of the issuer’s next annual stockholder meeting, whichever occurs first.
What is The Gallagher Revocable Trust’s role in the PMV Pharmaceuticals (PMVP) Form 4?
A footnote states that certain securities are held of record by The Gallagher Revocable Trust dated May 10, 2011, for which the reporting person serves as trustee. Some option interests are gifted to this trust, shifting record ownership while keeping the director involved as trustee.
When do Carol Giltner Gallagher’s PMV Pharmaceuticals options begin to vest?
The options vest on the earlier of June 4, 2027 or the date of PMV Pharmaceuticals’ next annual meeting of stockholders. This schedule ties vesting either to a fixed future date or to the timing of the company’s upcoming annual shareholder meeting, whichever arrives first.